[Effect of camphoramine chloroacetic platinum (CCP) on biomacromolecules in L1210 leukemic cells].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000378:metabolism; D005260:Female; D007939:Leukemia L1210 / Q000473:pathology*; D046911:Macromolecular Substances; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D009363:Neoplasm Proteins / Q000378:metabolism; D009944:Organoplatinum Compounds / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000378:metabolism
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D046911:Macromolecular Substances; D009363:Neoplasm Proteins; D009944:Organoplatinum Compounds; D012334:RNA, Neoplasm; C053095:camphoramine chloroacetic platinum